Pharming announces positive topline data in pediatric clinical trial of leniolisib
Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary ...
The Pharma Letter2 天
Positive leniolisib top-line data in pediatric clinical trial from Pharming
Netherlands-based Pharming Group today released positive top-line results of data from its Phase III clinical trial ...
Pharming Group N.V.: Pharming announces positive topline data in pediatric clinical trial ...
Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Data consistent with the improvements seen in the previously ...